FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2560135330> ?p ?o ?g. }

• W2560135330 endingPage "294" @default.
• W2560135330 startingPage "283" @default.
• W2560135330 abstract "Objective Growth hormone (GH) replacement therapy currently requires daily injections, which may cause distress and low compliance. C-terminal peptide (CTP)-modified growth hormone (MOD-4023) is being developed as a once-weekly dosing regimen in patients with GH deficiency (GHD). This study’s objective is to evaluate the safety, pharmacokinetics (PK), pharmacodynamics (PD) and efficacy of MOD-4023 administered once-weekly in GHD adults. Design 54 adults with GHD currently treated with daily GH were normalized and randomized into 4 weekly dosing cohorts of MOD-4023 at 18.5%, 37%, 55.5% or 123.4% of individual cumulative weekly molar hGH dose. The study included 2 stages: Stage A assessed the effectiveness and PK/PD profiles of the 4 dosing regimens of MOD-4023. Stage B was an extension period of once-weekly MOD-4023 administration (61.7% molar hGH content) to collect further safety data and confirm the results from Stage A. Results Dose-dependent response was observed for both PK and PD data of weekly MOD-4023 treatment. Insulin-like growth factor I (IGF-I) SDS levels were maintained within normal range. The 18.5% cohort was discontinued due to low efficacy. MOD-4023 was well tolerated and exhibited favorable safety profile in all dose cohorts. The reported adverse events were consistent with known GH-related side effects. Conclusions Once-weekly MOD-4023 administration in GHD adults was found to be clinically effective while maintaining a favorable safety profile and may obviate the need for daily injections. Weekly GH injections may improve compliance and overall outcome. The promising results achieved in this Phase 2 study led to a pivotal Phase 3 trial, which is currently ongoing." @default.
• W2560135330 created "2016-12-16" @default.
• W2560135330 creator A5024791254 @default.
• W2560135330 creator A5026290220 @default.
• W2560135330 creator A5026467693 @default.
• W2560135330 creator A5031543944 @default.
• W2560135330 creator A5035836380 @default.
• W2560135330 creator A5040992376 @default.
• W2560135330 creator A5044310510 @default.
• W2560135330 creator A5049091175 @default.
• W2560135330 creator A5057394610 @default.
• W2560135330 creator A5058073936 @default.
• W2560135330 creator A5060375158 @default.
• W2560135330 creator A5071142012 @default.
• W2560135330 creator A5074298217 @default.
• W2560135330 creator A5076292783 @default.
• W2560135330 creator A5083001014 @default.
• W2560135330 creator A5087190566 @default.
• W2560135330 creator A5087550212 @default.
• W2560135330 date "2017-03-01" @default.
• W2560135330 modified "2023-10-16" @default.
• W2560135330 title "MOD-4023, a long-acting carboxy-terminal peptide-modified human growth hormone: results of a Phase 2 study in growth hormone-deficient adults" @default.
• W2560135330 cites W1926632055 @default.
• W2560135330 cites W1957937187 @default.
• W2560135330 cites W1964279728 @default.
• W2560135330 cites W1965290697 @default.
• W2560135330 cites W1965755128 @default.
• W2560135330 cites W1971855331 @default.
• W2560135330 cites W1979103441 @default.
• W2560135330 cites W1985116028 @default.
• W2560135330 cites W2007891815 @default.
• W2560135330 cites W2014983285 @default.
• W2560135330 cites W2042399930 @default.
• W2560135330 cites W2043807987 @default.
• W2560135330 cites W2062026358 @default.
• W2560135330 cites W2080775457 @default.
• W2560135330 cites W2081600359 @default.
• W2560135330 cites W2082494913 @default.
• W2560135330 cites W2087995681 @default.
• W2560135330 cites W2088649681 @default.
• W2560135330 cites W2089464982 @default.
• W2560135330 cites W2090627812 @default.
• W2560135330 cites W2100836119 @default.
• W2560135330 cites W2127770204 @default.
• W2560135330 cites W2130988832 @default.
• W2560135330 cites W2138080929 @default.
• W2560135330 cites W2143793406 @default.
• W2560135330 cites W2148981079 @default.
• W2560135330 cites W2154872879 @default.
• W2560135330 cites W2158604505 @default.
• W2560135330 cites W2167362914 @default.
• W2560135330 cites W2170799379 @default.
• W2560135330 cites W2172860872 @default.
• W2560135330 cites W2190367334 @default.
• W2560135330 cites W2207735731 @default.
• W2560135330 cites W2309974931 @default.
• W2560135330 cites W2343383102 @default.
• W2560135330 cites W2592087460 @default.
• W2560135330 cites W4247966618 @default.
• W2560135330 cites W4248927401 @default.
• W2560135330 cites W4256141595 @default.
• W2560135330 doi "https://doi.org/10.1530/eje-16-0748" @default.
• W2560135330 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5292974" @default.
• W2560135330 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27932411" @default.
• W2560135330 hasPublicationYear "2017" @default.
• W2560135330 type Work @default.
• W2560135330 sameAs 2560135330 @default.
• W2560135330 citedByCount "35" @default.
• W2560135330 countsByYear W25601353302017 @default.
• W2560135330 countsByYear W25601353302018 @default.
• W2560135330 countsByYear W25601353302019 @default.
• W2560135330 countsByYear W25601353302020 @default.
• W2560135330 countsByYear W25601353302021 @default.
• W2560135330 countsByYear W25601353302022 @default.
• W2560135330 countsByYear W25601353302023 @default.
• W2560135330 crossrefType "journal-article" @default.
• W2560135330 hasAuthorship W2560135330A5024791254 @default.
• W2560135330 hasAuthorship W2560135330A5026290220 @default.
• W2560135330 hasAuthorship W2560135330A5026467693 @default.
• W2560135330 hasAuthorship W2560135330A5031543944 @default.
• W2560135330 hasAuthorship W2560135330A5035836380 @default.
• W2560135330 hasAuthorship W2560135330A5040992376 @default.
• W2560135330 hasAuthorship W2560135330A5044310510 @default.
• W2560135330 hasAuthorship W2560135330A5049091175 @default.
• W2560135330 hasAuthorship W2560135330A5057394610 @default.
• W2560135330 hasAuthorship W2560135330A5058073936 @default.
• W2560135330 hasAuthorship W2560135330A5060375158 @default.
• W2560135330 hasAuthorship W2560135330A5071142012 @default.
• W2560135330 hasAuthorship W2560135330A5074298217 @default.
• W2560135330 hasAuthorship W2560135330A5076292783 @default.
• W2560135330 hasAuthorship W2560135330A5083001014 @default.
• W2560135330 hasAuthorship W2560135330A5087190566 @default.
• W2560135330 hasAuthorship W2560135330A5087550212 @default.
• W2560135330 hasBestOaLocation W25601353301 @default.
• W2560135330 hasConcept C111113717 @default.
• W2560135330 hasConcept C112705442 @default.
• W2560135330 hasConcept C126322002 @default.
• W2560135330 hasConcept C134018914 @default.

• next